Hopewell Manufacturing Site
Princeton West Innovation Center, NJ USA
Our flagship U.S. biologics manufacturing and clinical R&D facility at the Princeton West Innovation Campus in Hopewell, N.J., spans 42 acres and represents an $800 million capital investment. This state-of-the-art facility, with 150,000 sq ft of space and a total of 8,000L cell culture capacity, supports both clinical- and commercial-stage biologics manufacturing, as well as clinical R&D capabilities, further complementing BeOne’s existing global network and enhancing our ability to deliver innovative therapies worldwide.
Drug Substance
Manufacturing Capabilities
- Total 8,000L Cell Culture Capacity
- Single-use System (4 x 2,000L)
- Batch, Fed-batch, and Perfusion
- Faster expansion through modular system
- Room reserved for additional 4 x 2,000L line
Drug Products
DP Production Lines
- Isolators
- Liquid Vials (clinical & commercial)
- Lypholized Vials (clinical & commercial)
- Label & Packaging
Warehouse
Equipped with Latest Technology
- ASRS (Automatic Search & Retrieval System)
- Storage Conditions: 2 – 8°C, -20°C, -70°C